Mohammed Bouhajib

617 total citations
16 papers, 206 citations indexed

About

Mohammed Bouhajib is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Mohammed Bouhajib has authored 16 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Mohammed Bouhajib's work include Inhalation and Respiratory Drug Delivery (3 papers), Attention Deficit Hyperactivity Disorder (2 papers) and Allergic Rhinitis and Sensitization (2 papers). Mohammed Bouhajib is often cited by papers focused on Inhalation and Respiratory Drug Delivery (3 papers), Attention Deficit Hyperactivity Disorder (2 papers) and Allergic Rhinitis and Sensitization (2 papers). Mohammed Bouhajib collaborates with scholars based in United States, Canada and Italy. Mohammed Bouhajib's co-authors include Josée Lagacé, Mahmoud Sharkawi, Christian Beaulac, Abdelwahab Omri, S Montplaisir, Lawrence M. Levin, Ari Mosenkis, Elliot V. Hersh, Raymond R. Townsend and Carrie Y. Peterson and has published in prestigious journals such as The FASEB Journal, Antimicrobial Agents and Chemotherapy and Pharmaceutical Research.

In The Last Decade

Mohammed Bouhajib

14 papers receiving 195 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammed Bouhajib United States 7 58 46 42 39 32 16 206
Timothy J. Bill United States 12 14 0.2× 23 0.5× 59 1.4× 127 3.3× 3 0.1× 24 446
Poul Erik Branebjerg Denmark 9 13 0.2× 50 1.1× 15 0.4× 70 1.8× 3 0.1× 11 312
Eun Hye Lee South Korea 8 16 0.3× 4 0.1× 113 2.7× 40 1.0× 131 4.1× 26 347
David P. Betten United States 8 60 1.0× 2 0.0× 34 0.8× 48 1.2× 7 0.2× 19 286
Marta Escribano Spain 7 24 0.4× 88 1.9× 37 0.9× 6 0.2× 8 0.3× 11 404
Agarwal Sp India 8 27 0.5× 3 0.1× 12 0.3× 16 0.4× 11 0.3× 24 221
S. Hüttner Germany 5 41 0.7× 2 0.0× 27 0.6× 20 0.5× 5 0.2× 8 187
Alaina M. Bever United States 9 12 0.2× 7 0.2× 38 0.9× 11 0.3× 6 0.2× 22 260
Roy A. Borchardt United States 8 74 1.3× 2 0.0× 103 2.5× 105 2.7× 5 0.2× 21 327
Edward L. Young Australia 5 20 0.3× 21 0.5× 32 0.8× 102 3.2× 18 232

Countries citing papers authored by Mohammed Bouhajib

Since Specialization
Citations

This map shows the geographic impact of Mohammed Bouhajib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Bouhajib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Bouhajib more than expected).

Fields of papers citing papers by Mohammed Bouhajib

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed Bouhajib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Bouhajib. The network helps show where Mohammed Bouhajib may publish in the future.

Co-authorship network of co-authors of Mohammed Bouhajib

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed Bouhajib. A scholar is included among the top collaborators of Mohammed Bouhajib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed Bouhajib. Mohammed Bouhajib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bouhajib, Mohammed, et al.. (2025). The pharmacokinetics and comparative bioavailabilty of oral and subcutaneous semaglutide in healthy volunteers. Journal of Basic and Clinical Physiology and Pharmacology. 36(2-3). 221–227.
2.
Kastelein, John J.P., Marc Ditmarsch, Andrew Hsieh, et al.. (2025). A Drug–Drug Interaction Study Evaluating the Pharmacokinetic Consequences of Obicetrapib Therapy on Atorvastatin or Rosuvastatin Levels in Healthy Volunteers. American Journal of Cardiovascular Drugs. 25(5). 693–702. 1 indexed citations
3.
Tal, Yuval, Limor Rubin, Oded Shamriz, et al.. (2023). Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for Anaphylaxis. The Journal of Allergy and Clinical Immunology In Practice. 11(10). 3047–3054. 13 indexed citations
4.
Bouhajib, Mohammed, et al.. (2022). A Novel Faster-Acting, Dry Powder-Based, Naloxone Intranasal Formulation for Opioid Overdose. Pharmaceutical Research. 39(5). 963–975. 12 indexed citations
6.
Bouhajib, Mohammed, et al.. (2020). The Pharmacokinetics of Fluticasone Furoate Given Intranasally in Healthy Subjects Using an Ultra-Sensitive Analytical Assay. Drug Research. 70(7). 310–316. 1 indexed citations
7.
Khalilieh, Sauzanne, Ka Lai Yee, Rosa I. Sánchez, et al.. (2019). Evaluation of the Pharmacokinetic Interaction Between Doravirine and Methadone. Clinical Pharmacology in Drug Development. 9(2). 151–161. 6 indexed citations
8.
Bouhajib, Mohammed, et al.. (2019). Evaluation of the Pharmacokinetics of Abiraterone Acetate and Abiraterone Following Single-Dose Administration of Abiraterone Acetate to Healthy Subjects. Clinical Drug Investigation. 39(3). 309–317. 10 indexed citations
9.
Bouhajib, Mohammed, et al.. (2019). An evaluation of the pharmacokinetics of tiotropium following a single-dose inhalation in healthy subjects using an ultra-sensitive bioanalytical method. Drug Development and Industrial Pharmacy. 45(12). 1915–1920. 3 indexed citations
11.
Herman, Barry K., Mohammed Bouhajib, Thomas King, Judith C. Kando, & Antonio Pardo. (2019). Single-Dose Pharmacokinetics of Amphetamine Extended-Release Oral Suspension in Healthy Adults. Journal of Attention Disorders. 25(6). 803–808. 2 indexed citations
13.
Hersh, Elliot V., Helen Giannakopoulos, Lawrence M. Levin, et al.. (2006). The pharmacokinetics and cardiovascular effects of high-dose articaine with 1:100,000 and 1:200,000 epinephrine. The Journal of the American Dental Association. 137(11). 1562–1571. 57 indexed citations
14.
Garneau, F.-X., et al.. (1994). The Glycosidically Bound Volatile Compounds ofPicea mariana(Mill.) B.S.P.. Journal of Essential Oil Research. 6(1). 43–46. 1 indexed citations
15.
Omri, Abdelwahab, Christian Beaulac, Mohammed Bouhajib, et al.. (1994). Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 38(5). 1090–1095. 71 indexed citations
16.
Jean, France-Ida, et al.. (1993). The Essential Oil and Glycosidically Bound Volatile Compounds ofTaxus canadensisMarsh. Journal of Essential Oil Research. 5(1). 7–11. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026